Blog
Non-alcoholic Steatohepatitis (NASH)
In our latest blog we discuss Non-alcoholic Steatohepatitis (NASH), how it is caused and how Cellomatics Biosciences is at the forefront of designing and validating
World Alzheimer’s Month
World Alzheimer’s Month takes place every September and is dedicated to raising awareness of the disease and challenging the stigma associated with it. In our
INNOBEX™: an in vitro model of the blood-brain barrier developed in house at Cellomatics
Over the years, several companies have designed different models to represent the blood-brain barrier (BBB) in vitro. These range from simple one cell type models
European expansion: meet Dr Pier Giorgio Amendola
Alongside its US expansion, Cellomatics is looking to consolidate its presence in Europe and has welcomed Dr Pier Giorgio Amendola to support with the company’s
Looking to the future: US expansion
The United States (US) is one of the biggest and most fast-growing biotech markets globally and Cellomatics is looking to further expand its client base
Posing (Neuro)inflammatory questions about dementia
To mark Parkinson’s Awareness Month our Senior Bioassay Scientist Dr Gareth Edwards delves into the role of neuroinflammation and its contribution to the global increase
Request a consultation with Cellomatics Biosciences today
Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.
To request a consultation where we can discuss your exact requirements, please contact a member of the team.
